Jonathan Davis, MD, MPHS

3.2K posts

Jonathan Davis, MD, MPHS banner
Jonathan Davis, MD, MPHS

Jonathan Davis, MD, MPHS

@JonathanDavisHF

Director @sfhealthnetwork HF Program Zuckerberg SF General Hospital @zsfgcare @ucsfcardiology. New Dad x2! Alum @WUSTLmed⬅️ @UCSFmedicine⬅️ @cornell he/his/him

San Francisco, CA Katılım Nisan 2014
588 Takip Edilen3.1K Takipçiler
Jonathan Davis, MD, MPHS retweetledi
Gregg Fonarow MD
Gregg Fonarow MD@gcfmd·
Considerations for Rx beyond the foundational 4 pillars of disease modifying guideline-directed medical therapy for HFrEF
Gregg Fonarow MD tweet media
English
1
15
38
1.8K
Jonathan Davis, MD, MPHS retweetledi
Steve Greene
Steve Greene@SJGreene_md·
@AndrewFoy82 @gcfmd @mvaduganathan @AndrewJSauer @dranulala @ShelleyZieroth @JavedButler1 @pedschwartzmann @JonathanDavisHF @HFA_President @ankeetbhatt To Mandrola's original point: 🔑is definition of "decompensated" We should not initiate BB in hemodynamic instability/shock But "decompensated" is not synonymous w/ entirety of a HF hospitalization. In-hospital/pre-discharge initiation BB is evidence-based routine approach.
English
0
1
9
282
Jonathan Davis, MD, MPHS retweetledi
Muthu Vaduganathan
Muthu Vaduganathan@mvaduganathan·
β-blockers safe pre-discharge in #HFrEF #COPERNICUS ☠️ benefit in recent decomp jamanetwork.com/journals/jama/… #STRONGHF rapid uptritration ⬇️ events thelancet.com/journals/lance… #IMPACTHF ⬆️ Rx persistence jacc.org/doi/10.1016/j.… #BCONVINCED stopping not helpful academic.oup.com/eurheartj/arti…
Muthu Vaduganathan tweet media
John Mandrola, MD@drjohnm

Heart failure colleagues. I would propose a new focus of emphasis Re the acute Rx of newly decompensated systolic failure. We should favor afterload reduction FIRST. Seminal Beta-blocker trials were in ambulatory outpts. Giving BB to decompensated failure is a mistake. IMO.

English
4
25
113
19.9K
Jonathan Davis, MD, MPHS
Jonathan Davis, MD, MPHS@JonathanDavisHF·
9/29 I start at Mercy St. Louis! Working at @UCSFHospitals/@ZSFGCare/@UCSFCardiology was a profound privilege. The community, patients, & colleagues gave me more than I can ever express. Please know how grateful I am to have been part of this extraordinary team.
English
8
3
31
3.2K
Jonathan Davis, MD, MPHS retweetledi
Nosheen Reza, MD, MS
Nosheen Reza, MD, MS@noshreza·
Pop in for any part of the hour — we’re excited to connect with you and chat about the amazing things we have going on at @JCFINT! @HFSA @JasonKatzMD @ElliottMillerMD @SarahChuzi @ShahzebKhanMD @JulieDoberne @hcg_md @Carnicelli_Ant @MartyTamMD @JonathanDavisHF @FarhanRazaMD
JCF Intersections@JCFINT

Join Editor in Chief @JasonKatzMD and Deputy Editor @noshreza for JCF-I Office Hours! Answering your questions on: ✅the journal’s inaugural publications ✅what they are looking for in submissions ✅exciting updates on what’s to come 🔗 Registration: bit.ly/3Hu9SRo

English
0
7
22
2.5K
Jonathan Davis, MD, MPHS retweetledi
Diego Segura-Rodríguez
Diego Segura-Rodríguez@SeguraCardio·
🚨🚨🚨 Just released: 2025 AHA/ACC Multisociety Guideline on High Blood Pressure in Adults‼️ A must-read update for all clinicians. Love this post? I appreciate sharing & following ❤️ #Hypertension #CardioTwitter #HTN2025 #AHA
Diego Segura-Rodríguez tweet mediaDiego Segura-Rodríguez tweet mediaDiego Segura-Rodríguez tweet mediaDiego Segura-Rodríguez tweet media
English
3
50
127
14.3K
Jonathan Davis, MD, MPHS retweetledi
Nosheen Reza, MD, MS
Nosheen Reza, MD, MS@noshreza·
Our 4th @JCFINT manuscript is now in press! 🚀 @MayoCVservices describes their experience with renal replacement therapy in patients with cardiogenic shock Important research at the intersection of 🫀+🫘 care! @HFSA @JasonKatzMD @ElliottMillerMD @SarahChuzi @ShahzebKhanMD
JCF Intersections@JCFINT

Among 1,498 CICU patients with cardiogenic shock, the need for renal replacement therapy (RRT)—especially CRRT—is strongly associated with worse outcomes. 📉 In-hospital mortality for CRRT: 56% 📈 One-year survival: <30% 🧵 Key findings below: 🔗 bit.ly/3Utjz5w

English
1
6
23
2.9K
Jonathan Davis, MD, MPHS retweetledi
Jason N. Katz
Jason N. Katz@JasonKatzMD·
It’s finally here! Bite-sized podcasts on high-yield Critical Care Cardiology topics! Whether you are commuting to work, taking a break from resuscitation, or leaving at the end of a long day - take a listen to these casual conversations full of education from amazing colleagues!
Society Of Critical Care Cardiology@SocietyOfCCC

🚨 IT’S HERE! 🚨 The wait is over...the podcast episode that’s about to break the internet has officially dropped! 🎙 🎧 Listen now: open.spotify.com/episode/66IRjG… Join us on Pre-Rounds Podcast hosted by @BalimSenmanMD, as @ElliottMillerMD breaks down VT Storm with life-saving tips for #ICU and #CICU physicians. This is critical care education like you’ve never heard before. #GreatestPodcastEver #VTStorm #SoCCC #PodcastLaunch #CriticalCare #PreRoundsPodcast @JasonKatzMD @AnnGageMD @jameshorowitzmd @CCCEnthusiasts

English
4
10
57
5.5K
Jonathan Davis, MD, MPHS retweetledi
Jeffrey Davis
Jeffrey Davis@JeffreyLDavis44·
Regs & Eggs is out! mcdermottplus.com/blog/regs-eggs… This week, I provide a high-level overview of the CY 2026 Medicare Physician Fee Schedule Proposed Rule as well as some key takeaways. Stakeholders have highly anticipated the release of this rule, as it represents the Trump administration’s first opportunity to enact Medicare physician payment policies that directly impact hundreds of thousands of physicians and other clinicians. And @CMSGov did wind up proposing many significant policies that will give people a lot to chew on – and that will take a while to fully digest. Given the breadth and depth of this regulation, stakeholders will need to carefully review and understand each part to fully grasp its implications
McDermott+@McDermottPlus

🚨 New Regs & Eggs is here! Jeffrey Davis breaks down the CY 2026 Medicare PFS Proposed Rule—Trump admin’s first big move on physician payment. 🍳📜 📖 Read the highlights: mcdermott.shp.so/l/TOUC8G

English
0
2
9
688
Jonathan Davis, MD, MPHS retweetledi
Muthu Vaduganathan
Muthu Vaduganathan@mvaduganathan·
Just 5 years ago, HFpEF was described as the “stepchild” of HF with no approved therapies. Today, there are 5 US FDA therapies: ✅ Empagliflozin (#EMPEROR) ✅ Dapagliflozin (#DELIVER) ✅ Sotagliflozin (#SOLOISTWHF) ✅ Sacubitril/Valsartan (#PARAGONHF) ✅ Finerenone (#FINEARTSHF)
Muthu Vaduganathan tweet media
English
12
155
600
41.8K
Jonathan Davis, MD, MPHS retweetledi
Carlos G Santos-Gallego, MD
Carlos G Santos-Gallego, MD@SantosGallegoMD·
Do not miss this Virtual Grand Rounds! @rachkataria is a superstar!
Chittur Sivaram MD MACP MACC@CASivaram1

🤩 We close current academic year with OU Virtual CV GR by Early Career 🌟 Dr. Rachna Kataria from Brown University 🤩 Join us on 6/26/25 to learn about CS care at non-VAD non-transplant centers oklahoma.zoom.us/j/96211329819?… @OUCollegeofMed @rachkataria @AHajduczok @hvanspall @ShashankSinhaMD @iamritu @DrJMarine @DrMarthaGulati @JasonKatzMD @noshreza @Babar_Basir @adityadoc1 @MMukherjeeMD @DrSharathS

English
1
2
15
1.9K
Jonathan Davis, MD, MPHS retweetledi
Anu Lala (Anuradha Lala-Trindade)
Anu Lala (Anuradha Lala-Trindade)@dranulala·
Vulnerable share: Change is always hard. Kids grow older. Schools change. Trainees move on. New challenges. The natural response? RESISTANCE. The more effective empowering response? Acceptance. 🙏🏽💜(working on it 🫣) Go easy on yourself during this time of transition 🌊
Anu Lala (Anuradha Lala-Trindade) tweet mediaAnu Lala (Anuradha Lala-Trindade) tweet media
English
7
7
79
4.6K

Keşfet

@mercysaintlouis @STLCounty @STLCityGov @American_Heart @ACCinTouch @HFSA @AndrewFoy82 @gcfmd